Ph2 clinical trial with paclitaxel in patients with endometrial cancer
Phase II Clinical Trial
An Open-label Multi-Center Phase 2 Clinical Trial Evaluating Sapanisertib and Serabelisib (PIKTOR) with Paclitaxel and a Substudy Evaluating PIKTOR with Paclitaxel plus an Insulin-Suppressing Diet in Patients with Advanced or Recurrent Endometrial Cancer
Participating Locations